scispace - formally typeset
Open AccessJournal ArticleDOI

Absence of signaling into CD4 + cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3 + regulatory T cells

TLDR
The absence of signaling via C3aR and C5aR resulted in lower expression of costimulatory molecules and interleukin 6 (IL-6) and more production of IL-10, which suppressed ongoing autoimmune disease.
Abstract
Complement provides costimulatory signals to T cells. Medof and colleagues demonstrate that an absence of complement signaling in naive T cells generates an autoinductive loop to drive induced regulatory T cells.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Transforming Growth Factor-β Signaling in Immunity and Cancer.

TL;DR: An overview of the complex biology of the TGF-β family and its context-dependent nature is presented and how this knowledge is being leveraged to unleash the immune system against the tumor is discussed.
Journal ArticleDOI

Keeping It All Going—Complement Meets Metabolism

TL;DR: Current knowledge about complement’s emerging relationship with the cellular metabolism machinery is covered with a focus on the functional differences between serum-circulating versus intracellularly active complement during normal cell survival and induction of effector functions.
Journal ArticleDOI

Complement System Part II: Role in Immunity.

TL;DR: Recent advances in the understanding of the role of complement in physiology and pathology are discussed, showing that complement contributes to a large variety of conditions, far exceeding the classical examples of diseases associated with complement deficiencies.
Journal ArticleDOI

Development and Maintenance of Regulatory T cells

TL;DR: Understanding how epigenetic alterations and Foxp3 expression coordinately control Treg-cell-specific gene regulation will enable better control of immune responses by targeting the generation and maintenance of Treg cells.
Journal ArticleDOI

Overview of complement activation and regulation.

TL;DR: Many kidney disorders have been linked to abnormal complement activation, including immune-complex–mediated glomerulonephritis and rare genetic kidney diseases, but also tubulointerstitial injury associated with progressive proteinuric diseases or ischemia-reperfusion.
References
More filters
Journal ArticleDOI

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

TL;DR: It is shown that IL-6, an acute phase protein induced during inflammation, completely inhibits the generation of Foxp3+ Treg cells induced by TGF-β, and the data demonstrate a dichotomy in thegeneration of pathogenic (TH17) T cells that induce autoimmunity and regulatory (Foxp3+) T Cells that inhibit autoimmune tissue injury.
Journal ArticleDOI

Mechanisms of foxp3+ T regulatory cell-mediated suppression.

TL;DR: The in vitro model systems that have been developed to define the mechanisms used by Treg cells to suppress a large number of distinct target cell types are reviewed.
Journal ArticleDOI

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

TL;DR: New ways of treating immunological diseases by targeting Treg cells at the cellular and molecular levels are envisaged.
Journal ArticleDOI

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells.

TL;DR: Exposure of endogenous FOXP3, in humans, is not sufficient to induce regulatory T cell activity or to identify Treg cells, as it is demonstrated that it is also expressed in activated nonsuppressive T cells.
Journal ArticleDOI

How are T H 2-type immune responses initiated and amplified?

TL;DR: The involvement of allergen- and parasite product-mediated activation of epithelial cells, basophils and dendritic cells and the functions of the cytokines interleukin-4 (IL-4), IL-25, IL-33 and thymic stromal lymphopoietin in the initiation and amplification of TH2-type immune responses in vivo are discussed.
Related Papers (5)